NEWS
MSD’s legacy of antimicrobial innovation and action
AmCham News tags
- Accounting / Financial
- AmCham Norway
- Company Profiles
- Education / Research
- Entertainment
- Food & Beverage
- Government
- Healthcare
- Hotel/ Restaurants/ Conferences
- Insurance
- International Leadership Interview Series
- Membership Guide
- Publications
- Rising Leaders
- Technology
- Trade
- Travel
Archive tags
Business News tags
- Accounting / Financial
- Airline / Travel
- Automobile / Transport
- Chemicals / Metals
- Communications/PR/Media
- Culture / Lifestyle
- Defense / Security
- Education / Research
- Energy
- Entertainment & Lifestyle
- Financial / Investment
- Food & Beverage
- Government
- Health
- Human Resources
- Insurance
- IP & Innovation
- Legal
- Management Consulting
- Manufacturing
- Pharmaceutical
- Politics
- Property / Real Estate
- Seafood
- Shipping & Offshore
- Statistics
- Tax
- Technology
- Trade
< Back to all news
MSD’s legacy of antimicrobial innovation and action
Business
Date posted: 26.10.2023
Category: Business News
Delivering on our commitment to fight infectious diseases for more than a century.
For more than 100 years, MSD has contributed to the discovery and development of novel medicines and vaccines to fight infectious diseases. With the growing burden of antimicrobial resistance (AMR), we’ve focused on stopping the increasing threat of AMR.
Read full article here.
Source: MSD